Briggs Morrison, Chief Executive Officer at Syndax Pharmaceuticals Inc (SNDX), sold 35,156 shares at $20.00 ($703K) on 2021-12-17, disclosed to the SEC on 2021-12-20.
Open-market sale of $703k SNDX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SNDX | SELL | 2023-08-10 | $1.9M | — | Filing → |
| SNDX | SELL | 2023-07-11 | $1.1M | — | Filing → |
| SNDX | SELL | 2023-06-09 | $2.2M | — | Filing → |